Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.560
0.00 (0.00%)
Aug 17, 2026, 11:56 AM EDT - Market open
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $94.11 million as of August 17, 2026. Its market cap has decreased by -70.85% in one year.
Market Cap
94.11M
Enterprise Value
49.16M
1-Year Change
-70.85%
Ranking
Category
Stock Price
$1.56
ChartMarket Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $94.11M, an increase of 152.98%. That is a compound annual growth rate of 7.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 94.11M | -69.80% |
| Dec 31, 2025 | 311.60M | 4.85% |
| Dec 31, 2024 | 297.20M | 43.92% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
| May 2, 2014 | 37.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncolytics Biotech | 99.54M |
| Fortress Biotech | 97.72M |
| Kalaris Therapeutics | 97.12M |
| PolyPid | 96.28M |
| Cognition Therapeutics | 96.04M |
| Biomea Fusion | 95.68M |
| Pelthos Therapeutics | 95.58M |
| Gain Therapeutics | 92.52M |